NCT04648345

Brief Summary

Purpose: to evaluate the efficacy and safety of erector spinal block (ESB) for analgesia in laparoscopic cholecystectomy(LC). Method: This study is a randomized, single-blind, controlled clinical trial. Pre-operative ultrasound-guided bilateral erector spinae plane block will be performed in the ESPB group. Vertebral side block will be performed in the VSB group. And the control group will receive local anaesthesia after the surgery. Intraoperative and postoperative analgesia effect and side effects will be compared between the three groups.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2020

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 1, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

December 1, 2020

Status Verified

November 1, 2020

Enrollment Period

3 months

First QC Date

November 3, 2020

Last Update Submit

November 23, 2020

Conditions

Keywords

erector spinal plane blockanalgesialaparoscopic cholecystectomy

Outcome Measures

Primary Outcomes (3)

  • Pain intensity at rest(Hour 2)

    Using the Numeric Rating Scale (NRS) to evaluate the pain intensity at rest two hours after the surgery.

    Hour 2

  • Pain intensity at rest (Hour 6)

    Using the Numeric Rating Scale (NRS) to evaluate the pain intensity at rest six hours after the surgery.

    Hour 6

  • Pain intensity at rest (Hour 24)

    Using the Numeric Rating Scale (NRS) to evaluate the pain intensity at rest 24 hours after the surgery.

    Hour 24

Secondary Outcomes (1)

  • The overall dose of remifentanil

    During the surgery

Study Arms (3)

Erector spinal plane block group (ESPB group)

EXPERIMENTAL

After induction of general anesthesia, pre-operative ultrasound-guided bilateral erector spinae plane block will be performed in the ESPB group.

Procedure: Erector spinal plane block

Vertebral side block group (VSB group)

ACTIVE COMPARATOR

After induction of general anesthesia, pre-operative ultrasound-guided bilateral vertebral side block will be performed in the VSB group.

Procedure: Erector spinal plane block

Local block group (LB group)

PLACEBO COMPARATOR

Local block will be performed at the surgical incisions after the surgery under general anesthesia.

Procedure: Erector spinal plane block

Interventions

After induction of general anesthesia, pre-operative ultrasound-guided bilateral erector spinae plane block/ vertebral side block will be performed in the ESPB/VSB group. Local block will be performed at the surgical incisions after the surgery under general anesthesia. All the intervention will be performed without patients' awareness.

Also known as: Vertebral side block, Local block
Erector spinal plane block group (ESPB group)Local block group (LB group)Vertebral side block group (VSB group)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status 1-3
  • Scheduled for elective laparoscopic cholecystectomy surgery under general anesthesia

You may not qualify if:

  • patient refusal
  • pregnancy
  • history of allergy to study drugs
  • neurological and cognitive disorders
  • coagulopathy
  • chronic pain disorders
  • infections at the injection site
  • history of abdominal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized, single-blinded, controlled clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2020

First Posted

December 1, 2020

Study Start

December 1, 2020

Primary Completion

March 1, 2021

Study Completion

May 1, 2021

Last Updated

December 1, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share